Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples